MACKENZIE FINANCIAL CORP - BIOCRYST PHARMACEUTICALS INC ownership

BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 234 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.15 and the average weighting 0.2%.

Quarter-by-quarter ownership
MACKENZIE FINANCIAL CORP ownership history of BIOCRYST PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$86,111
-76.5%
13,413
-74.2%
0.00%
-100.0%
Q2 2023$367,178
-25.2%
52,082
-11.5%
0.00%0.0%
Q1 2023$491,059
+100.3%
58,880
+175.7%
0.00%
Q4 2022$245,213
-63.0%
21,360
-59.4%
0.00%
-100.0%
Q3 2022$663,000
+165.2%
52,587
+122.3%
0.00%
Q2 2022$250,000
-13.8%
23,656
+32.9%
0.00%
Q1 2022$290,000
+93.3%
17,806
+70.8%
0.00%
Q3 2021$150,00010,4230.00%
Other shareholders
BIOCRYST PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Burrage Capital Management LLC 1,105,673$8,237,0006.28%
Sarissa Capital Management LP 8,175,000$60,903,0006.22%
ORACLE INVESTMENT MANAGEMENT INC 2,980,870$22,207,0002.78%
DG Capital Management, LLC 1,075,732$8,014,0001.70%
Ghost Tree Capital, LLC 900,000$6,705,0001.49%
Parkman Healthcare Partners LLC 538,370$4,011,0001.03%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 5,835,810$43,477,0000.86%
Formidable Asset Management, LLC 470,419$3,470,0000.80%
KNOTT DAVID M 219,461$1,635,0000.74%
Altium Capital Management LP 250,000$1,863,0000.70%
View complete list of BIOCRYST PHARMACEUTICALS INC shareholders